about
Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulumThe knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human diseaseAn adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertensionMutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophyRole of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression.Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.Altered β-adrenergic response in mice lacking myotonic dystrophy protein kinaseGene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max.Emerging role of microRNAs in cardiovascular biology.MicroRNAs control gene expression: importance for cardiac development and pathophysiology.Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis.Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment.Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.T cell costimulation blockade blunts pressure overload-induced heart failure.Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity.Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart.Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.The importance of being ncRNAs: from bit players as "junk DNA" to rising stars on the stage of the pharmaceutical industry.NF-κB mediated miR-26a regulation in cardiac fibrosis.Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform.Inhalation of peptide-loaded nanoparticles improves heart failure.Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.HEXIM1: a new player in myocardial hypertrophy?Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells.Human stem cells for heart failure treatment ready for prime time?MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.Deciphering the β-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?Akt regulates L-type Ca2+ channel activity by modulating Cavα1 protein stability.A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseasesCarbon Monoxide Levels Experienced by Heavy Smokers Impair Aerobic Capacity and Cardiac Contractility and Induce Pathological Hypertrophy
P50
Q24321799-B558FEB8-FEE5-43D4-AF11-C34A8376128DQ24606673-C43E21C9-800A-4222-AE88-8F86A32C68DBQ27469506-E6060671-3057-43C9-AA32-2B83F63C393DQ28565620-1B4D9AD0-E467-4E86-8A7C-E09C0C46A5D9Q28771365-27541C00-223F-4D13-97A4-4BEBCC920A06Q33305207-696A4579-006D-4C62-B545-B514DC06F92AQ33633673-08CF3A9D-2323-40BD-945F-769BAED06F84Q33685877-FE0FE5A6-F253-4B37-9C6D-08506A16C358Q33798113-20630F6F-6AB9-4828-BDF2-5AFF8ED06A78Q34028756-8E1B9FA8-8E6E-4759-9031-AA2A92093F51Q34906347-D8F93C00-4A49-47F1-A328-C1619E7B103AQ36174612-69556008-A1C1-4FC7-8723-BD325970B5DFQ36977813-8A100BA7-C6F1-48DB-A257-18C4E6163CA1Q37026583-13F0F0E8-ABD6-481D-8305-0CB8CA9E174CQ37122791-80323FB3-F6C3-4733-948C-EAFB9800701FQ37139777-B77A571B-EBE9-4486-AB82-5BDA748FA94FQ37178191-364D7862-1D25-43B3-ACED-23350C12609AQ37234352-7DDE854A-B97B-4A7A-93D9-59A416BFB9CDQ37690286-CA9E2D3C-E9AC-4EA0-8F4C-F5D51E89E30BQ37693592-EBA8E452-E903-4916-98D1-3240D8546418Q38786123-27B79F49-7F42-4600-8715-6AE0B3E3AF9CQ39189258-61A309DD-E975-4221-95D6-751EAE1FEF39Q40025464-BB4DA24B-7CC0-4538-9730-A1EC7CA9621DQ40036242-8A1F9775-DD8B-4E86-9100-155BAE317801Q42361722-2F14FC5D-BE68-4649-A6A4-8EFA0E39F8ADQ46054688-F45B0658-E54C-460A-9402-C49277626B4BQ46057693-91F8EA54-CCF5-47EA-BF80-09942C0B3E5BQ48223842-99A936E4-444D-4112-BA7D-68F8AF078952Q50089772-F89943D8-3887-4780-92E0-689C37548F74Q50720019-D7717521-F658-4374-9B65-0EC985F559A0Q50949000-99743AE1-2E62-44CB-9D81-5095D03906EBQ50951210-12BCC51E-97B9-44A7-9D89-BB211F89E922Q51597916-31A72CA7-7677-40AD-9473-523E2C3BA5D5Q52669426-84AD8F11-F3D4-44B9-91BB-54E33B5171ABQ53518420-E5598CA4-3427-4D71-BE90-78C72009FD62Q54566995-C8D8F5C1-D291-48CA-A98E-7F33C09C6ECAQ55345618-EACA222A-1193-4DF1-B11D-5E8B3284BAE2Q55465436-7EDA3B99-AAE3-451A-8299-B31AB44EA3DAQ60183931-E814BCF8-5BD4-4818-831E-09B545FB181BQ61896369-63B03C47-0E2B-4BFE-9A77-A465530AF993
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniele Catalucci
@ast
Daniele Catalucci
@en
Daniele Catalucci
@es
Daniele Catalucci
@nl
Daniele Catalucci
@sl
type
label
Daniele Catalucci
@ast
Daniele Catalucci
@en
Daniele Catalucci
@es
Daniele Catalucci
@nl
Daniele Catalucci
@sl
prefLabel
Daniele Catalucci
@ast
Daniele Catalucci
@en
Daniele Catalucci
@es
Daniele Catalucci
@nl
Daniele Catalucci
@sl
P106
P1153
23567447700
P31
P496
0000-0001-7041-6114